MFG
AMPH icon

Magnus Financial Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Magnus Financial Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,664
Closed -$204K – 543
2019
Q2 		$204K Buy
+9,664
New +$202K 0.04% 458

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnus Financial Group's AMPH Position: Q3 2019 in Review

Magnus Financial Group sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2019, closing a stake of 9,664 shares — an estimated $204K sold.

Magnus Financial Group first reported a position in AMPH in Q2 2019 and held it in 1 quarter. The position peaked at $204K in Q2 2019. 134 funds tracked by Wall St. Rank hold AMPH as of Q3 2019.

  • Magnus Financial Group reported no remaining Amphastar Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Magnus Financial Group sold 9,664 Amphastar Pharmaceuticals shares in Q3 2019, an estimated $204K.
  • Magnus Financial Group first reported a position in Amphastar Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Magnus Financial Group's Amphastar Pharmaceuticals position peaked at $204K in Q2 2019.
  • 134 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2019.

Based on Magnus Financial Group's 13F filing for Q3 2019, filed 8 Nov 2019.